Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study
The trajectory of cognitive decline in patients with late-onset Alzheimer's disease varies widely. Genetic variations in CLU, PICALM, and CR1 are associated with Alzheimer's disease, but it is unknown whether they exert their effects by altering cognitive trajectory in elderly individuals...
Uloženo v:
| Vydáno v: | The American journal of psychiatry Ročník 169; číslo 9; s. 954 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.09.2012
|
| Témata: | |
| ISSN: | 1535-7228, 1535-7228 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The trajectory of cognitive decline in patients with late-onset Alzheimer's disease varies widely. Genetic variations in CLU, PICALM, and CR1 are associated with Alzheimer's disease, but it is unknown whether they exert their effects by altering cognitive trajectory in elderly individuals at risk for the disease.
The authors developed a Bayesian model to fit cognitive trajectories in a cohort of elderly subjects and test for genetic effects. They first validated the model's ability to detect the previously established effects of APOE ε4 alleles on age at cognitive decline and of psychosis on the rate of cognitive decline in 802 subjects from the Cardiovascular Health Cognition Study who did not have dementia at study entry and developed incident dementia during follow-up. The authors then evaluated the effects of CLU, PICALM, and CR1 on age and rate of decline in 1,831 subjects who did not have dementia at study entry and then did or did not develop incident dementia by study's end.
The model generated robust fits to the observed cognitive trajectory data, and validation analysis supported the model's utility. CLU and CR1 were associated with more rapid cognitive decline. PICALM was associated with an earlier age at midpoint of cognitive decline. Associations remained after accounting for the effects of APOE and demographic factors.
Evaluation of cognitive trajectories provides a powerful approach to dissecting genetic effects on the processes leading to cognitive deterioration and Alzheimer's disease. |
|---|---|
| AbstractList | The trajectory of cognitive decline in patients with late-onset Alzheimer's disease varies widely. Genetic variations in CLU, PICALM, and CR1 are associated with Alzheimer's disease, but it is unknown whether they exert their effects by altering cognitive trajectory in elderly individuals at risk for the disease.OBJECTIVEThe trajectory of cognitive decline in patients with late-onset Alzheimer's disease varies widely. Genetic variations in CLU, PICALM, and CR1 are associated with Alzheimer's disease, but it is unknown whether they exert their effects by altering cognitive trajectory in elderly individuals at risk for the disease.The authors developed a Bayesian model to fit cognitive trajectories in a cohort of elderly subjects and test for genetic effects. They first validated the model's ability to detect the previously established effects of APOE ε4 alleles on age at cognitive decline and of psychosis on the rate of cognitive decline in 802 subjects from the Cardiovascular Health Cognition Study who did not have dementia at study entry and developed incident dementia during follow-up. The authors then evaluated the effects of CLU, PICALM, and CR1 on age and rate of decline in 1,831 subjects who did not have dementia at study entry and then did or did not develop incident dementia by study's end.METHODThe authors developed a Bayesian model to fit cognitive trajectories in a cohort of elderly subjects and test for genetic effects. They first validated the model's ability to detect the previously established effects of APOE ε4 alleles on age at cognitive decline and of psychosis on the rate of cognitive decline in 802 subjects from the Cardiovascular Health Cognition Study who did not have dementia at study entry and developed incident dementia during follow-up. The authors then evaluated the effects of CLU, PICALM, and CR1 on age and rate of decline in 1,831 subjects who did not have dementia at study entry and then did or did not develop incident dementia by study's end.The model generated robust fits to the observed cognitive trajectory data, and validation analysis supported the model's utility. CLU and CR1 were associated with more rapid cognitive decline. PICALM was associated with an earlier age at midpoint of cognitive decline. Associations remained after accounting for the effects of APOE and demographic factors.RESULTSThe model generated robust fits to the observed cognitive trajectory data, and validation analysis supported the model's utility. CLU and CR1 were associated with more rapid cognitive decline. PICALM was associated with an earlier age at midpoint of cognitive decline. Associations remained after accounting for the effects of APOE and demographic factors.Evaluation of cognitive trajectories provides a powerful approach to dissecting genetic effects on the processes leading to cognitive deterioration and Alzheimer's disease.CONCLUSIONSEvaluation of cognitive trajectories provides a powerful approach to dissecting genetic effects on the processes leading to cognitive deterioration and Alzheimer's disease. The trajectory of cognitive decline in patients with late-onset Alzheimer's disease varies widely. Genetic variations in CLU, PICALM, and CR1 are associated with Alzheimer's disease, but it is unknown whether they exert their effects by altering cognitive trajectory in elderly individuals at risk for the disease. The authors developed a Bayesian model to fit cognitive trajectories in a cohort of elderly subjects and test for genetic effects. They first validated the model's ability to detect the previously established effects of APOE ε4 alleles on age at cognitive decline and of psychosis on the rate of cognitive decline in 802 subjects from the Cardiovascular Health Cognition Study who did not have dementia at study entry and developed incident dementia during follow-up. The authors then evaluated the effects of CLU, PICALM, and CR1 on age and rate of decline in 1,831 subjects who did not have dementia at study entry and then did or did not develop incident dementia by study's end. The model generated robust fits to the observed cognitive trajectory data, and validation analysis supported the model's utility. CLU and CR1 were associated with more rapid cognitive decline. PICALM was associated with an earlier age at midpoint of cognitive decline. Associations remained after accounting for the effects of APOE and demographic factors. Evaluation of cognitive trajectories provides a powerful approach to dissecting genetic effects on the processes leading to cognitive deterioration and Alzheimer's disease. |
| Author | Sweet, Robert A Weamer, Elise A Kuller, Lewis H Seltman, Howard Emanuel, James E Lopez, Oscar L Becker, James T Bis, Joshua C DeMichele-Sweet, Mary Ann A |
| Author_xml | – sequence: 1 givenname: Robert A surname: Sweet fullname: Sweet, Robert A email: sweetra@upmc.edu organization: Department of Psychiatry, University of Pittsburgh, Pittsburgh, USA. sweetra@upmc.edu – sequence: 2 givenname: Howard surname: Seltman fullname: Seltman, Howard – sequence: 3 givenname: James E surname: Emanuel fullname: Emanuel, James E – sequence: 4 givenname: Oscar L surname: Lopez fullname: Lopez, Oscar L – sequence: 5 givenname: James T surname: Becker fullname: Becker, James T – sequence: 6 givenname: Joshua C surname: Bis fullname: Bis, Joshua C – sequence: 7 givenname: Elise A surname: Weamer fullname: Weamer, Elise A – sequence: 8 givenname: Mary Ann A surname: DeMichele-Sweet fullname: DeMichele-Sweet, Mary Ann A – sequence: 9 givenname: Lewis H surname: Kuller fullname: Kuller, Lewis H |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22952074$$D View this record in MEDLINE/PubMed |
| BookMark | eNpN0E1PwzAMBuAIDbEP-AtTbnDpSJx26Y7TNBjSJA7AuUpTZ8vo15J00vj1FDEkfLFf65EPHpNB3dRIyJSzGedy_qja1s7UoZ0B49CvOPCUJ1dkxBORRBIgHfybh2Ts_YH1JSTckCHAIgEm4xE5ro1BHWhj6LL82qOt0N17WliPyiN11n_SHdboaVPT4NShx42zP9lQ3exqG-wJqelqHWxPbK_2SFfKFbY5Ka-7Ujm6QVWGPX0LXXG-JddGlR7vLn1CPp7W76tNtH19flktt5GK5SJESjNZSJMIlmiBqUIOKjWcFQhsbuJcgALN8lhIoeeQI0Ke5wmalJlCpAsDE_Lwe7d1zbFDH7LKeo1lqWpsOp9xJtJkAVKwnk4vtMsrLLLW2Uq5c_b3JvgGV7lv7Q |
| CitedBy_id | crossref_primary_10_3389_fneur_2021_735036 crossref_primary_10_1016_j_exger_2020_110951 crossref_primary_10_3390_cells11243994 crossref_primary_10_1007_s12035_014_8878_3 crossref_primary_10_1038_mp_2015_62 crossref_primary_10_1002_ajmg_b_32509 crossref_primary_10_1016_j_neurobiolaging_2014_04_022 crossref_primary_10_1038_s41380_021_01152_8 crossref_primary_10_1016_j_anbehav_2014_06_013 crossref_primary_10_1016_j_neurobiolaging_2013_05_028 crossref_primary_10_1007_s12017_013_8225_2 crossref_primary_10_1111_jnc_12261 crossref_primary_10_3389_fnagi_2017_00055 crossref_primary_10_1186_s13195_018_0458_8 crossref_primary_10_2217_pgs_13_161 crossref_primary_10_1016_j_neurobiolaging_2015_08_006 crossref_primary_10_1007_s12035_015_9098_1 crossref_primary_10_1007_s00429_014_0738_4 crossref_primary_10_1016_j_trci_2017_03_004 crossref_primary_10_1016_j_biopsych_2013_08_020 crossref_primary_10_1007_s12031_016_0804_x crossref_primary_10_1002_gps_4145 crossref_primary_10_3389_fnins_2020_00324 crossref_primary_10_1007_s13311_022_01185_z crossref_primary_10_1007_s12035_014_8761_2 crossref_primary_10_1097_WAD_0000000000000137 crossref_primary_10_1007_s13206_015_9306_8 crossref_primary_10_1016_j_neurobiolaging_2014_07_042 crossref_primary_10_1002_sim_8100 crossref_primary_10_1038_mp_2017_81 crossref_primary_10_3233_JAD_190342 crossref_primary_10_1007_s12035_016_9886_2 crossref_primary_10_3389_fnins_2019_00164 crossref_primary_10_3233_JAD_201182 crossref_primary_10_3233_JAD_191214 crossref_primary_10_1016_j_dadm_2015_08_002 crossref_primary_10_1007_s12035_015_9343_7 crossref_primary_10_1016_j_euroneuro_2015_11_004 crossref_primary_10_1016_j_neurobiolaging_2014_03_003 crossref_primary_10_1007_s12035_016_0358_5 crossref_primary_10_2217_nmt_13_40 crossref_primary_10_1016_j_tins_2017_06_002 crossref_primary_10_1002_hbm_22494 crossref_primary_10_3389_fimmu_2019_02585 crossref_primary_10_1016_j_neuroscience_2014_09_061 crossref_primary_10_1002_gps_4326 crossref_primary_10_1016_j_arr_2016_02_002 crossref_primary_10_1007_s11064_020_03176_y crossref_primary_10_3233_JAD_160774 crossref_primary_10_1016_j_jocn_2014_03_015 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1176/appi.ajp.2012.11121815 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1535-7228 |
| ExternalDocumentID | 22952074 |
| Genre | Validation Study Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: N01-HC-85086 – fundername: NHLBI NIH HHS grantid: N01 HC055222 – fundername: NHLBI NIH HHS grantid: U01 HL080295 – fundername: NIA NIH HHS grantid: AG20098 – fundername: NHLBI NIH HHS grantid: N01 HC075150 – fundername: NIA NIH HHS grantid: AG15928 – fundername: NHLBI NIH HHS grantid: HL087251 – fundername: NHLBI NIH HHS grantid: N01-HC-85081 – fundername: NHLBI NIH HHS grantid: N01 HC085079 – fundername: NHLBI NIH HHS grantid: N01 HC015103 |
| GroupedDBID | --- --Z -DZ -~X .55 .GJ 08P 0WA 1CY 1HT 1KJ 1QT 23M 2QL 2WC 354 3O- 4.4 41~ 53G 5GY 5RE 6J9 6TJ 7K8 85S 8F7 8R4 8R5 AAAHA AAFWJ AAIKC AAJMC AAKAS AAMNW AAQQT AAWTL AAWTO AAYJJ ABDPE ABIVO ABPPZ ABUFD ABZEH ACBMB ACGFO ACGOD ACHQT ACNCT ADBBV ADCOW ADMHG ADXHL ADZCM AENEX AERZD AETEA AFAZI AFFNX AGHSJ AGNAY AHJKT AHMBA AI. ALMA_UNASSIGNED_HOLDINGS ASUFR BAJDF BAWUL BCR BKOMP BLC CGR CS3 CUY CVF DIK E3Z EBS ECM EIF EJD EX3 F5P F8P FA8 FJW G0H GOZPB GRPMH H13 HF~ HZ~ J5H L7B LPU LXL LXN MVM N4W N9A NEJ NHB NPM OHT OK1 OVD P-O P2P PEA PQQKQ Q.- Q2X RWL RXW RYA S10 SJN SKT TAE TEORI TR2 TWZ UBC UHB UKR ULE UPT UQL VH1 VVN WH7 WHG WOQ WOW X4V X6Y X7M XOL XSW XZL YFH YOC YQI YQJ YRY YSK YWH YXB YYQ YZZ ZCA ZGI ZHY ZKB ZRR ZXP ZY1 ~A~ ~X8 7X8 XJT |
| ID | FETCH-LOGICAL-a479t-ac07d7f5305c3e8ae12a8f10de206f4b32a2c0b4373c62bee2bbb5ef80fd389f2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 57 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000308278100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1535-7228 |
| IngestDate | Thu Oct 02 09:58:45 EDT 2025 Mon Nov 17 00:32:21 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a479t-ac07d7f5305c3e8ae12a8f10de206f4b32a2c0b4373c62bee2bbb5ef80fd389f2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 22952074 |
| PQID | 1038592730 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1038592730 pubmed_primary_22952074 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-09-01 |
| PublicationDateYYYYMMDD | 2012-09-01 |
| PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The American journal of psychiatry |
| PublicationTitleAlternate | Am J Psychiatry |
| PublicationYear | 2012 |
| SSID | ssj0000372 |
| Score | 2.316008 |
| Snippet | The trajectory of cognitive decline in patients with late-onset Alzheimer's disease varies widely. Genetic variations in CLU, PICALM, and CR1 are associated... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 954 |
| SubjectTerms | Age of Onset Aged Alleles Alzheimer Disease - complications Alzheimer Disease - genetics Alzheimer Disease - psychology Apolipoprotein E4 - genetics Bayes Theorem Clusterin - genetics Cohort Studies Dementia - complications Dementia - genetics Dementia - psychology Disease Progression Female Genetic Predisposition to Disease - genetics Humans Male Models, Psychological Monomeric Clathrin Assembly Proteins - genetics Polymorphism, Single Nucleotide - genetics Receptors, Complement 3b - genetics Risk Factors |
| Title | Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22952074 https://www.proquest.com/docview/1038592730 |
| Volume | 169 |
| WOSCitedRecordID | wos000308278100012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3Igg-VdP0kvZJxnD4srEHhb2VJE1ch7ZbOwX99ea0mcMHQfAlUGig5Jycc5rz5fsQupLm31_FJHVoTKXju5F0hAeDJkAubhK4imqxCTYYRKNRPLQHbpWFVS5iYh2o00LCGfktEHkHsUm25G46c0A1CrqrVkJjFbU8U8qAV7PRki2ceLV4k9nUINlKI3tD2GUhtIezGz4BxkqXQtyAVBf8XmbW6aa3_d8P3UFbttDEncYzdtGKyvfQRt-20vfRrOEtxoXGnZfPscpeVXldYduwwQA5x88QCHGR43nJJ_XxfgbPGn-DjjDkRbAtzsxbY4W7P_CtuLnlhAGt-HGAnnr3j90Hx-ovONxn8dzhkrCU6cCEBGlMxpVLeaRdkipKQu0Lj3IqiQByJBlSoRQVQgRKR0Snpg7S9BCt5UWujhEmqeaMRzL2uOsHgnHuEhVyX4rAF77kbXS5WMzE-Dc0LXiuircqWS5nGx01FkmmDRFHAlLk1NRAJ3-YfYo2wdQNPOwMtbTZ3eocrcv3eVaVF7XjmHEw7H8BHODPQQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Alzheimer%27s+disease+risk+genes+on+trajectories+of+cognitive+function+in+the+Cardiovascular+Health+Study&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Sweet%2C+Robert+A&rft.au=Seltman%2C+Howard&rft.au=Emanuel%2C+James+E&rft.au=Lopez%2C+Oscar+L&rft.date=2012-09-01&rft.eissn=1535-7228&rft.volume=169&rft.issue=9&rft.spage=954&rft_id=info:doi/10.1176%2Fappi.ajp.2012.11121815&rft_id=info%3Apmid%2F22952074&rft_id=info%3Apmid%2F22952074&rft.externalDocID=22952074 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-7228&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-7228&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-7228&client=summon |